Cargando…
Potential Cost-Effectiveness of a Universal Influenza Vaccine in Older Adults
BACKGROUND AND OBJECTIVES: “Universal” vaccines that could have multistrain and multiyear effectiveness are being developed. Their potential cost-effectiveness in geriatric populations is unknown. RESEARCH DESIGN AND METHODS: A Markov model estimated effects of a theoretical universal influenza vacc...
Autores principales: | France, Glenson, Wateska, Angela R, Nowalk, Mary Patricia, DePasse, Jay, Raviotta, Jonathan M, Shim, Eunha, Zimmerman, Richard K, Smith, Kenneth J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293081/ https://www.ncbi.nlm.nih.gov/pubmed/30569023 http://dx.doi.org/10.1093/geroni/igy035 |
Ejemplares similares
-
Cost-Effectiveness of Newly Recommended Pneumococcal Vaccination Strategies in Older Underserved Minority Adults in the USA
por: Smith, Kenneth J., et al.
Publicado: (2022) -
Cost-effectiveness of increasing vaccination in high-risk adults aged 18–64 Years: a model-based decision analysis
por: Wateska, Angela R., et al.
Publicado: (2018) -
Should older adult pneumococcal vaccination recommendations change due to decreased vaccination in children during the pandemic? A cost-effectiveness analysis
por: Smith, Kenneth J., et al.
Publicado: (2021) -
Vaccine effectiveness of recombinant and standard dose influenza vaccines against outpatient illness during 2018–2019 and 2019–2020 calculated using a retrospective test-negative design
por: Zimmerman, Richard K., et al.
Publicado: (2023) -
Viral infections in outpatients with medically attended acute respiratory illness during the 2012–2013 influenza season
por: Zimmerman, Richard K, et al.
Publicado: (2015)